drugset / Trial / NCT05422378
A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty
RandomizedParallel-groupDouble-blindTreatment
Summary
Dose-ranging, randomized, double-blind, vehicle-controlled study
Timeline
- Start
- 2022-08-01
- Primary completion
- 2023-02-03
- Completion
- 2023-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STP705 | Small interfering RNA (siRNA) | 120 ug/ml | Subcutaneous |
| Subject | STP705 | Small interfering RNA (siRNA) | 240 ug/ml | Subcutaneous |
| Subject | STP705 | Small interfering RNA (siRNA) | 320 ug/ml | Subcutaneous |